NEW DELHI - On the heels of a study showing one million people die yearly in India from smoking-related illness, Pfizer plans to launch its anti-smoking tablet Chantix (varenicline) by the end of the month, Pfizer India told PharmAsia News
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Company surprises investors with Jørgensen's exit but insists its strategy will not change.
The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.
Recent moves in the industry include changes at the top at Akamis Bio, Innospera Pharma & Ispen, plus Astellas Korea appoints an ex-Novartis Korea executive.
